Biomarin Pharmaceutical Inc
Change company Symbol lookup
Select an option...
BMRN Biomarin Pharmaceutical Inc
BLDP Ballard Power Systems Inc
FOX Fox Corp
JNJ Johnson & Johnson
ERBB American Green Inc
PEGA Pegasystems Inc
NDRA ENDRA Life Sciences Inc
HIG-G Hartford Financial Services Group Inc
NLLSY Nel ASA
AHEXY Adecco Group AG
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

BioMarin Pharmaceutical Inc is a biotechnology company. The Company develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. The Company’s portfolio consists of commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases. The Company's commercial products include Aldurazyme (laronidase), Brineura (cerliponase alfa), Kuvan (sapropterin dihydrochloride), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Vimizim (elosulfase alpha) and Voxzogo (vosoritide). The Company's pipeline includes Valoctocogene Roxaparvovec for Severe Hemophilia A, Vosoritide for Achondroplasia, BMN 307 for Phenylketonuria (PKU) and BMN 331 for Hereditary Angioedema (HAE).

Premarket

Last Trade
Delayed
$86.22
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$86.22
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
1

10-day average volume:
1,741,532
1
  • Prev Close
    86.22
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    1.7M
  • Last (time)
    4:00p ET 01/24/22
  • Last (size)
    1
  • 52-Wk Range
    71.59 - 92.17
    LowHigh
  • (10/27/21 - 11/22/21)
    6.46%
  • 29.3%
  • Market Cap
    15.8B
  • Shares Outstanding
    183.6M
  • -0.25
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.5
  • 93.30
  • (% of float 12/31/21)
    5.61

Latest News

January 14, 2022
11:16 pm ET
PR Newswire
January 10, 2022
9:31 am ET
PR Newswire
7:55 am ET
MarketWatch
January 09, 2022
3:13 pm ET
PR Newswire
January 02, 2022
8:24 am ET
Newsfile
December 29, 2021
9:00 pm ET
Globe Newswire
December 22, 2021
8:42 pm ET
PR Newswire
4:20 pm ET
Accesswire
4:00 pm ET
BusinessWire
11:01 am ET
Accesswire
9:26 am ET
Newsfile
December 21, 2021
10:17 pm ET
PR Newswire
1:41 pm ET
Accesswire
1:16 pm ET
Globe Newswire
1:01 pm ET
Accesswire
11:43 am ET
PR Newswire
8:01 am ET
Accesswire
December 20, 2021
3:44 pm ET
Newsfile
10:04 am ET
Globe Newswire
9:50 am ET
Accesswire
7:45 am ET
Accesswire
December 19, 2021
9:36 pm ET
Globe Newswire
December 17, 2021
12:01 pm ET
Accesswire
8:01 am ET
Accesswire
December 16, 2021
7:30 pm ET
Globe Newswire
6:53 pm ET
Newsfile
4:05 pm ET
PR Newswire
4:02 pm ET
Accesswire
12:36 pm ET
Accesswire
10:01 am ET
Accesswire
December 15, 2021
8:49 pm ET
PR Newswire
1:21 pm ET
Accesswire
7:45 am ET
Accesswire
December 14, 2021
10:09 pm ET
PR Newswire
9:00 pm ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.